Predictive model of unfavorable outcomes for multidrug-resistant tuberculosis

Arroyo, Luiz Henrique; Ramos, Antônio Carlos Vieira; Yamamura, Mellina; Berra, Thais Zamboni; Alves, Luana Seles; Belchior, Aylana de Souza; Santos, Danielle Talita; Alves, Josilene Dália; Campoy, Laura Terenciani; Arcoverde, Marcos Augusto Moraes; Bollela, Valdes Roberto; Bombarda, Sidney; Nunes, Carla; Arcêncio, Ricardo Alexandre.
Rev. saúde pública (Online) ; 53: 77, jan. 2019. tab, graf
Artículo en Inglés | LILACS | ID: biblio-1043339

Documentos relacionados

  1. More Tailored Approaches to Tuberculosis Treatment and Prevention.
  2. Spatial Analysis of Drug-Susceptible and Multidrug-Resistant Cases of Tuberculosis, Ho Chi Minh City, Vietnam, 2020-2023.
  3. Global burden of MDR-TB and XDR-TB attributable to high fasting plasma glucose from 1990 to 2019: a retrospective analysis based on the global burden of disease study 2019.
  4. Determinants of catastrophic costs among households affected by multi-drug resistant tuberculosis in Ho Chi Minh City, Viet Nam: a prospective cohort study.
  5. Transmission of multidrug-resistant tuberculosis within family households by DTM-PCR and MIRU-VNTR genotyping.
  6. Confronting and Coping with Multidrug-Resistant Tuberculosis: Life Experiences in Thailand.
  7. Pediatric multi-drug-resistant tuberculosis in Germany - diagnostic and therapeutic challenges of an "orphan disease".
  8. Use of a whole genome sequencing-based approach for <i>Mycobacterium tuberculosis</i> surveillance in Europe in 2017-2019: an ECDC pilot study.
  9. Two-stage targeted maximum likelihood estimation for mixed aggregate and individual participant data analysis with an application to multidrug resistant tuberculosis.
  10. Risk factors for diagnosis and treatment delay among patients with multidrug-resistant tuberculosis in Hunan Province, China.